A Pilot Study Using Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
Status: Recruiting
Location: See location...
Intervention Type: Procedure, Other, Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This pilot clinical trial studies how well ultrasound works in detecting oxaliplatin-induced neuropathy in patients with gastrointestinal cancer. Ultrasound may work better in diagnosing and detecting neuropathy in gastrointestinal cancer patients treated with the chemotherapy drug called a oxaliplatin.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Gastrointestinal cancer
• Colorectal cancer (any stage)
• Previously or currently receiving oxaliplatin -based chemotherapy.
• Clinical symptoms of peripheral neuropathy noted in medical record and suspected to be secondary to oxaliplatin -based therapy.
• Ability and willingness to understand and sign an informed consent.
Locations
United States
North Carolina
Wake Forest Baptist Comprehensive Cancer Center
RECRUITING
Winston-salem
Contact Information
Primary
Ashley Fansler, RN
arcarrol@wakehealth.edu
336-716-5440
Time Frame
Start Date: 2019-12-17
Estimated Completion Date: 2026-04
Participants
Target number of participants: 20
Treatments
Experimental: Ultrasound
Undergo peripheral nerve ultrasound
Related Therapeutic Areas
Sponsors
Leads: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)